Patent · US Active

Liquid pharmaceutical composition of adalimumab

US10688187B2 · kind B2 · utility

0Cited by

6References

3Claims

0Family size

Assignee

Intas Pharmaceuticals Ltd. · IN

Inventors

Himanshu GADGIL · Sayla, IN
Chandresh CHHATBAR · Ahmedabad, IN
Vijaykant PANDEY · Ahmedabad, IN

Key dates

Filing date	Feb 18, 2015
Grant date	Jun 23, 2020
Priority date	—
Expiry date	Jul 30, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K16/241
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A liquid pharmaceutical composition having an anti-TNFα antibody, a buffer, a stabilizer, and a surfactant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.